Novel inhaled PI3Kdelta inhibitor with improved properties for respiratory disease treatment Dec. 7, 2018
Faron identifies optimal subgroup of patients for Traumakine treatment in INTEREST study Dec. 5, 2018
aTyr Pharma initiates phase Ib/IIa study of ATYR-1923 in patients with pulmonary sarcoidosis Dec. 5, 2018
RSS